A synthetic peptide for use as a blocking control in assays to test for specificity of GABRG2 antibody, Alternative Names: GABRG2 control peptide, GABRG2 antibody Blocking Peptide, Anti-GABRG2 Blocking Peptide, Gamma-Aminobutyric Acid Blocking Peptide, Gaba A Receptor Gamma 2 Blocking Peptide, CAE2 Blocking Peptide, ECA2 Blocking Peptide, GEFSP3 Blocking Peptide
GABRG2
Reaktivität: Human, Ratte, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
GABRG2
(gamma-aminobutyric Acid (GABA) A Receptor, gamma 2 (GABRG2))
Hintergrund
Gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the brain, mediates neuronal inhibition by binding to GABA receptors. The type A GABA receptors are pentameric chloride channels assembled from among many genetic variants of GABA(A) subunits. GABRG2 is the gamma 2 subunit of GABA(A) receptor. Mutations in this gene have been associated with epilepsy and febrile seizures.